| Market Capitalization (Millions $) |
4,933 |
| Shares
Outstanding (Millions) |
93 |
| Employees |
59 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-96 |
| Cash Flow (TTM) (Millions $) |
363 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Terns Pharmaceuticals Inc is a clinical stage biopharmaceutical company that focuses on the discovery and development of innovative small molecule therapies for liver diseases and cancers. The company is based in Foster City, California, and was founded in 201
Terns Pharmaceuticals is led by a seasoned management team with extensive experience in drug discovery, development, and commercialization. The company has established collaborations with leading academic institutions and drug discovery companies to develop novel therapeutics.
The company's lead drug candidate, TERN-101, is a liver-targeted FXR agonist under development for the treatment of non-alcoholic steatohepatitis (NASH), a common liver disease that affects millions of people worldwide. FXR agonists are a class of drugs that activate the farnesoid X receptor, a protein that plays a crucial role in regulating bile acid metabolism and liver function.
TERN-101 has demonstrated promising results in preclinical studies and early clinical trials, showing significant reductions in liver fat and inflammation. The drug has also shown a favorable safety and tolerability profile, with no serious adverse events reported.
In addition to TERN-101, Terns Pharmaceuticals has a pipeline of other small molecule drug candidates under development for the treatment of liver diseases and solid tumors. These drugs target specific pathways and molecular targets involved in the progression and spread of cancer and liver disease.
Terns Pharmaceuticals has received funding from leading venture capital firms, including OrbiMed, Lilly Asia Ventures, and Vivo Capital, among others. The company is also actively seeking partnerships and collaborations to advance its drug development programs and bring novel therapies to patients in need.
Company Address: 1065 East Hillsdale Blvd. Foster City 94404 CA
Company Phone Number: 525-5535 Stock Exchange / Ticker: NASDAQ TERN
|
%
